{
    "2021-08-14": [
        [
            {
                "time": "2023-10-18",
                "original_text": "3 Reasons Why You Should Consider Buying Pfizer Stock",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "stock",
                        "buying",
                        "reasons"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "U.S. FDA Approves TICOVAC™, Pfizer’s Tick-Borne Encephalitis (TBE) Vaccine",
                "features": {
                    "keywords": [
                        "FDA",
                        "approval",
                        "TICOVAC",
                        "Pfizer",
                        "vaccine",
                        "Tick-Borne Encephalitis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}